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Background: The aim of this study is to evaluate the role of NADPH oxidase in primary intestinal epithelial cells
during the active phase of UC.
Methods: The primary human colonic epithelial cells were isolated from 19 patients with mild to moderate
inflammatory activity of UC and 14 controls using chelation method. The cells were cultivated under the effect of
mediators. Viability of cells was assessed by fluorescent microscopy. Production of reactive oxygen species (ROS) by
the cells was measured fluorimetrically using Amplex Red. Production of TNF-α cytokine by the colonic epithelial
cells was analysed by ELISA.
Results: The results of our study showed that unstimulated cells of UC patients had a decreased viability, increased
ROS production, but similar TNF-α level when compared to the controls. Stimulation with LPS increased hydrogen
peroxide and TNF-α level in the UC group. Treatment of colonic epithelial cells with NADPH oxidase inhibitor
increased cell viability decreased the levels of ROS and TNF-α in the LPS-treated cells isolated from UC patients.
Conclusions: Our study showed that bacterial endotoxins induced NADPH oxidase activation in the colonic
epithelial cells. Moreover, we revealed that treatment with NADPH oxidase inhibitors had a protective effect against
pro-inflammatory action of LPS in human colonic epithelium cells during inflammation.
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Ulcerative colitis (UC) is a chronic inflammatory bowel
disease (IBD) that affects intestinal mucosa. The patho-
genic mechanisms of UC are complex and involve in-
teraction between genetic, host immune system and
environmental factors. One of the major factors in the
onset of UC is inappropriate mucosal immune response
towards the intestinal microbiota leading to mucosal
tissue damage and chronic inflammation [1-3].* Correspondence: l.kupcinskas@gmail.com
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reproduction in any medium, provided the orIncreased production of reactive oxygen species (ROS)
and oxidant-induced protein or lipid alterations have
been implicated in tissue damage observed in chronic
inflammatory disorders, such as IBD [4]. The key pro-
ducers of the superoxide anions in the colon are non-
phagocytic and phagocytic cells. The epithelial NADPH
oxidase homologs (Nox1, Nox3, Nox4, Nox5, DUOX1,
and DUOX2) generate a higher level of superoxide in
the colon compared to phagocyte NADPH oxidase [5].
Previous studies have shown that epithelial NADPH oxi-
dase mediating formation of ROS might be involved in
host defence system and inflammatory responses at mu-
cosal surfaces [6-8]. ROS production in the intestinal
mucosal biopsies is increased during inflammation [9].
Moreover, genetic mutations in genes encoding compo-
nents of the NADPH complex have been associated with
IBD susceptibility. The variations have been found intral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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complex (including p47phox and p67phox and RAC2) to
the membrane [10,11].
Despite the profound consequences of either absent or
excessive ROS generation in the intestinal tract, little is
known about the molecular pathways controlling ROS
production via NOX enzymes in the primary intestinal
epithelial cells derived from UC patients. Therefore, in
this study we aimed to evaluate the role of NADPH oxi-
dase in primary intestinal epithelial cells during the ac-
tive phase of UC.
Methods
Patients
The colonoscopic biopsies were obtained from 19 patients
with UC (men n = 9 (medium age ± SD= 45.8 ± 20.1),
women n = 10 (medium age ± SD= 42 ± 18)) and 14 con-
trol subjects (men n = 7 (medium age ± SD= 44 ± 19.5),
women n = 7 (medium age (years ± SD) = 47 ± 15.3)). UC
patients and control subjects were recruited in the Depart-
ment of Gastroenterology, Hospital of Lithuanian Univer-
sity of Health Sciences. The diagnosis of UC was based on
standard clinical, endoscopic, radiological, and histological
criteria [12-14]. Patients with mild to moderate disease ac-
tivity were included in the study (Mayo UC Endoscopic
Score 1 to 2). Histologically, these patients had active
chronic UC as well. The individuals did not use steroid or
immunosuppressive therapy at least 3 months before the
biopsies specimens have been obtained. Only five patients
had used 5-aminosalicylate (5-ASA) preparations as main-
tenance therapy (≤ 1.5 g/d). None of the patients had re-
ceived iron supplementation.
The control group consisted of patients with irritable
bowel disease or functional constipation. Individuals
were included if they had a normal colonoscopy and un-
inflamed mucosa on histopathological examination. All
patients had a routine colonoscopy performed as a part of
their planned examination programme. In healthy sub-
jects, eight to ten biopsies (5–10 mg wet weight each)
were taken from transverse or descending colon. The
same numbers of biopsies from patients with UC were
collected from endoscopically inflamed colonic mucosa.
Biopsies were immediately placed in a chilled Dulbecco’s
modified Eagle medium containing 10 mM HEPES buffer
and antibiotics (50 IU/ml penicillin, 50 mg/ml strepto-
mycin and 0.5 mg/ml of gentamicin). Written informed
consent was obtained from all study participants. The
study has been approved by the Kaunas Regional Biomed-
ical Research Ethics Committee (Protocol No. BE – 2–49).
Isolation and cultivation of primary human colonic
epithelial cells
All chemicals were obtained from Sigma-Aldrich (Steinheim,
Germany) unless otherwise stated. The primary humancolonic epithelial cells were isolated using chelation
method according to Seidelin et al. [15]. The incubation
time in the chelation buffer lasted for 40–45 min at room
temperature that allowed the isolation of single epithelial
cells. The isolated epithelial cells were suspended in
DMEM with 15% fetal calf serum (FCS), 10 mM HEPES
buffer and antibiotics. Approximately 107 cells per well
were cultured with mediators (20 μg/ml of lipopolysac-
charide (LPS), 1 mM of apocynin, 20 μg/ml LPS + 1 mM
apocynin, 200 units/ml of catalase) in 24-well plates
coated with bovine dermal collagen for 24 hours at 37°C
in an atmosphere of 5% CO2 and at 90% relative humidity.
After 24 hours, supernatants were collected and stored
at −20°C.Measurement of hydrogen peroxide production
NADPH oxidase generates superoxide, which is rapidly
converted to hydrogen peroxide [16]. Hydrogen peroxide
production in cells was measured fluorimetrically using
1 μM Amplex Red and 10 units/ml Horseradish peroxid-
ase. Colonic epithelial cells (approximately 105 cells/ml)
were re-suspended in the phosphate-buffered saline
(PBS) and incubated with either 5 units/ml of catalase
(endogenous control), or 10 μg/ml of LPS, or 10 μM of
diphenylene iodonium (DPI), or 10 μg/ml LPS + 10 μM
DPI for 30 min at 37°C. Then the Amplex Red and per-
oxidase were added and the rate of hydrogen peroxide
production was quantitated at 544 nm excitation and
590 nm emission by a microplate fluorometer (Fluoroskan
Ascent, Thermo Fisher Scientific, Waltham, MA).
Apocynin (used as NADPH oxidase inhibitor during cell
cultivation) interferes with detection of ROS in assay sys-
tems selective for hydrogen peroxide or hydroxyl radicals.
This inhibitor acts as a radical scavenger and inhibits
Amplex Red oxidation. Thus ROS are not measured ac-
curately and cannot reflect the effect of apocynin on the
NADPH oxidase activity [17]. Therefore, for the assess-
ment of NADPH oxidase activity we applied another
large-spectrum inhibitor DPI.Assessment of cell viability
The viability of human colonic epithelial cells in the cul-
tures was assessed by propidium iodide (PI, 7 μM) and
Hoechst 33342 (4 μg/ml) staining using a fluorescence
microscope (OLYMPUS IX71S1F-3, Tokyo, Japan). PI-
negative cells with weak Hoechst-staining were considered
to be viable, whereas cells showing nuclear shrinkage or
fragmentation and intensive Hoechst staining but still
lacking PI staining were classified as chromatin con-
densed/fragmented (apoptotic). PI-positive cells were clas-
sified as necrotic. Human colonic epithelial cells were
counted in at least 5 microscopic fields per well (three
wells per treatment). Data are expressed as percentage of
Figure 1 Assessment of viability of human colonic epithelial
cells. Where indicated, cells were incubated with 20 μg/ml LPS,
1 mM apocynin (apoc), 20 μg/ml LPS + 1 mM apocynin, 200 units/ml
catalase (Cat), and control without stimulation for 24 h. A - control
group, B - UC group. *Statistically significant difference between
control and another subgroups in the control or UC groups.
**Statistically significant difference between LPS and LPS + Apocynin
subgroups in the control or UC groups. #Statistically significant
difference between control and UC groups. Statistically significant,
as p <0.05.
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cells per field.
Assessment of TNF -α concentration
Concentration of TNF-α was assessed in the supernatants
of primary colonic epithelial cells cultures using commer-
cially available two-site ELISA kit (Invitrogen, Carlsbad,
CA). The lowest limit of sensitivity of test systems for
TNF-α was 3 pg/ml. The optical densities at 450 nm and
at a correction wavelength of 490 nm were measured on
ELISA micro plate reader (MRX micro plate reader, Dynex
Technologies, Denkendorf, Germany).
Statistical analysis
Statistical analyses were done using the SPSS statistical
package (version 16.0; Chicago, IL). Data in text and fig-
ures are presented as means ± standard error (SE). The
results were analysed by one-way ANOVA. The least sig-
nificant difference (LSD) test was used as a post hoc test.
P-value of <0.05 was accepted as statistically significant.
Results
Assessment of viability of human colonic epithelial cells
Firstly, we investigated whether there was any difference
in survival of colonic epithelial cells isolated from UC
patients and control individuals in cell culture. As shown
in Figure 1, after 24 h in culture the vast majority of the
control cells were viable and accounted for 72%, necrosis
was observed in 18% and apoptosis in 10% of cells. The
viability of cells isolated from UC patients and main-
tained in cell culture for 24 h was significantly lower
than in control group (Figure 1A and B). Treatment of
cells with NADPH oxidase inhibitor apocynin or with
catalase (which selectively removes H2O2) increased the
viability of the UC group cells reaching the survival level
of untreated cells. In contrast, apocynin as well as cata-
lase had no effect on cell survival in the control group.
Stimulation of colonic epithelial cells with LPS signifi-
cantly reduced the number of live cells from 72% to 57%
and increased necrotic cell death from 18% to 37% in the
control group; whereas the viability of cells in UC group
remained unchanged upon LPS treatment (Figure 1B).
The cultivation of cells with LPS and apocynin increased
the viability of the cells in the control and UC groups (to
76% and 78%, respectively) by decreasing the number of
necrotic cells (Figure 1A and B). The percentage of apop-
totic cells was 5–8% in all study groups.
Assessment of hydrogen peroxide production in cells
Further, we analysed the ROS generation in primary co-
lonic epithelial cells. As shown in Figure 2, the level of
extracellular hydrogen peroxide production was approxi-
mately two times higher in epithelial cells of UC patients
compared to the control group. Similar results wereobtained when hydrogen peroxide production was mea-
sured directly in the colonic biopsies (Figure 2B). The
treatment of colonic epithelial cells with catalase signifi-
cantly decreased the level of extracellular hydrogen per-
oxide production in both experimental groups.
DPI slightly decreased the level of ROS production in
both UC and control groups, however, the differences
were not statistically significant. The treatment of cells
with LPS significantly increased the production of hydro-
gen peroxide in cells of both study groups (Figure 2A).
The addition of DPI to LPS-treated colonic epithelial cells
significantly decreased (by 1.7 fold) the level of ROS
production in the UC group. In control group, DPI
also diminished hydrogen peroxide production in LPS-
treated cells, though the effect of DPI per se was not sta-
tistically significant due to higher variability of results
(Figure 2A).
Figure 2 Assessment of hydrogen peroxide production. A - colonic epithelial cells were incubated for 30 min with 5 units/ml catalase (Cat),
10 μg/ml LPS, 10 μM DPI, 10 μg/ml LPS + 10 μM DPI or control without stimulation (where indicated). B - colonic biopsies (10 mg) of UC patients
and control subjects were incubated without stimulation for 30 min. *Statistically significant difference between control and another subgroups in
the control group. @Statistically significant difference between control and another subgroups in the UC group. & Statistically significant
difference between LPS and LPS + DPI subgroups in the UC group. #Statistically significant difference between control and UC groups. Statistically
significant, as p <0.05.
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cells
In addition, we analysed the influence of NADPH oxi-
dase on the production of pro-inflammatory cytokine
TNF-α. As shown in Figure 3, the highest concentrations
of TNF-α were determined in cells of UC patients after
stimulation with LPS. The level of cytokine production
was approximately three-fold higher in LPS treated UC
cells when compared to UC cells without stimulation
and control group cells treated with LPS. In the UC
group, treatment of cells with LPS and NADPH oxidase
inhibitor apocynin decreased the levels of TNF-α pro-
duction approximately 2.5-fold as compared with the
LPS treated colonic epithelial cells. The differences of
TNF-α concentration between untreated and treated
cells in the control group were insignificant.Figure 3 Assessment of TNF-α production by human colonic
epithelial cells. Cells were incubated for 24 h with 20 μg/ml of LPS,
1 mM of apocynin (Apoc), 20 μg/ml LPS + 1 mM apocynin or control
without stimulation (as indicated). After incubation cell media were
collected and TNF-α concentration was measured as described in
Methods. *Statistically significant difference between control and LPS
subgroups in the UC group. **Statistically significant difference
between LPS and LPS + apocynin subgroups in the UC group.
#Statistically significant difference between LPS subgroup in the UC
and control groups. Statistically significant, as p <0.05.Discussion
Functional studies have indicated that increased activity
of NADPH oxidase contributes to the development of
colon inflammation [5,18]. Inhibition of this enzyme
represents an attractive therapeutic target for the treat-
ment of many diseases. Apocynin has been used as an
inhibitor of the complex NADPH oxidase in many ex-
perimental models of inflammation involving phagocytic
and non-phagocytic cells [19-21]. In this study, we ex-
amined the influence of superoxide generating NADPHoxidase in primary intestinal epithelial cells during the
active phase of UC.
In the current study we showed that unstimulated cells
of UC patients had a decreased viability, increased ROS
production, and similar TNF-α level when compared to
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UC as increased cell death and excessive ROS produc-
tion are typical processes on-going during inflammation.
Previous studies have shown that the level of TNF-α
may correlate with the grade of inflammation in UC
[22,23]. Similar levels of TNF-α observed in UC and
control groups could be linked with absence of severe
disease activity cases within our cohort of UC patients.
The results of our study showed that sensitisation of
colonic epithelial cells with bacterial products were re-
quired for activation of NADPH oxidase. Cell viability in
normal epithelial cells was dramatically decreased in the
presence of LPS and assessment of extracellular hydro-
gen peroxide production showed increase in ROS pro-
duction. This observation suggests that innate immune
system may activate protective cascades against micro-
bial invaders; whereas minor changes in TNF-α level
may indicate suspended immune response towards mi-
crobial products. It is well known that ROS production
is rapidly elevated during infection, serving to facilitate
pathogen clearance as well as contributing to signalling
cascades related to inflammation, cell proliferation, and
immune responses [24]. In the UC group the response
to microbial stimulation resulted in an increased produc-
tion of oxidants and pro-inflammatory cytokine [24,25].
LPS-induced inflammatory responses are more intense
and acute in UC patients because mechanisms responsible
for bacterial recognition are unbalanced [25]. However, we
cannot exclude the possibility that the presence of phago-
cytic cells might have affected ROS production and TNF-
α concentration in the cell cultures from UC patients.
Animal models and in vitro cell culture studies have
shown that apocynin possesses anti-inflammatory activity
[19] and protects non-phagocytic cells from damage in-
duced by bacterial products and can reduce damage in the
colon tissues [26-28]. However, the impact of NADPH
oxidase inhibitory components has not been previously
shown in primary colon epithelial cell cultures. The im-
pact of apocynin in our control group was minor; whereas
in the UC group the inhibitor significantly increased cell
viability and reduced TNF-α in the LPS-treated colonic
epithelial cells. These findings indicate that NADPH oxi-
dase inhibition has an anti-inflammatory effect in human
colonic epithelium cells during inflammation. Similar find-
ings have been observed in lung endothelial cells during
inflammation. The suppression of NADPH oxidase activ-
ity by apocynin in the lung endothelial cells resulted in a
significant reduction of all parameters of inflammation
measured, including TNF-α level [29,30].
The results of this study confirmed that NADPH oxi-
dase is directly involved in LPS-induced ROS generation
in the primary colonic epithelial cells and revealed the in-
flammation reducing effect of NADPH oxidase inhibitors.
Based on the findings observed in the studies performedin the cancer cell cultures [27,31], we suggest that a mo-
lecular mechanism for activation of NADPH oxidase in
colonic epithelial cells may be associated with a toll-like
receptor (TLR) pathway, where LPS strains potently
stimulate ROS production by colon NADPH oxidase
through a TLR4 [31-33]. Further studies should be de-
signed to determine the mechanism of LPS/TLR4/TNF-α/
colon NADPH oxidase signalling in colonic epithelial cells
and its contribution to UC etiopathogenesis.
Conclusion
In conclusion, we showed that bacterial endotoxins were
required for NADPH oxidase activation in the colonic
epithelial cells. Moreover, we revealed that treatment
with NADPH oxidase inhibitors had a protective effect
against pro-inflammatory action of LPS in human co-
lonic epithelium cells during inflammation.
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